HMMR and non-small cell lung carcinoma: In addition to other known cancer targets, the HA-synthesizing and -degrading enzymes, as well as HA receptors (e.g.CD44 and RHAMM) are upregulated in NSCLC cells, resulting in enhanced HA turnover through its synthesis and degradation [10].